Fulcrum Therapeutics, Inc.
2021 Q1 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 146 | 0.0% | 12,883 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 137 | 0.0% | 19,887 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 65 | 0.0% | 22,411 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 110 | 0.0% | 23,470 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 85 | 0.0% | 23,774 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 152 | 0.0% | 24,480 | 6/30/2024 |
| 2023 Q1 | 5/15/2023 | 49 | 0.0% | 17,020 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 124 | 0.0% | 17,020 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 121 | 0.0% | 15,011 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 73 | 0.0% | 14,970 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 274 | 0.0% | 11,572 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 254 | 0.0% | 14,341 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 395 | 0.0% | 14,007 | 9/30/2021 |
| 2021 Q1 | 5/3/2021 | 135 | 0.0% | 11,460 | 3/31/2021 |